Beyond the Primary Endpoint: Cardiometabolic and GH-Axis Signals A fair comparison should acknowledge the secondary signals each peptide generated, without inflating them into approved benefits
The newly discovered conjunctive use of GLP-1RA can improve clinical outcomes in patients with multiple chronic illnesses that have overlapping pathophysiology and help improve quality of life with early introduction
It has anti-inflammatory properties that help soothe the muscle tissue & reduce soreness overnight
1 H NMR (300 MHz, DMSO) 8.63 (d, J = 5.2 Hz, 2H), 8.09 (d, J = 72.6 Hz, 4H), 7.83 (q, J = 8.2 Hz, 8H), 3.44 (d, J = 4.5 Hz, 4H)
O'Brien W, Stenman G, Sager R
Our peptides meet rigorous internal quality standards